Additional Evidence That End-of-Treatment Fluorodeoxyglucose-Positron Emission Tomography Evaluation Is Necessary in Advanced Hodgkin Lymphoma

J Clin Oncol. 2018 Jul 10;36(20):2124-2125. doi: 10.1200/JCO.2018.78.6780. Epub 2018 May 23.

Authors

Charles Mesguich¹, Krimo Bouabdallah¹, Noël Milpied¹, Elif Hindié¹

Affiliation

¹ Charles Mesguich, Krimo Bouabdallah, Noël Milpied, and Elif Hindié, Bordeaux University Hospital, Bordeaux, France.

PMID: 29791291
DOI: 10.1200/JCO.2018.78.6780

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Dacarbazine
Doxorubicin
Hodgkin Disease*
Humans
Multimodal Imaging
Positron-Emission Tomography
Vinblastine

Substances

Bleomycin
Vinblastine
Dacarbazine
Doxorubicin